docetaxel,sotorasib
amgen
['docetaxel', 'sclc', 'lcsm,(-blcsm)', 'nsclc', 'biomarker', 'codebreak 200', 'sotorasib']
avm: hypothesis generating biomarker subgroup analyses of codebreak 200 sotorasib vs docetaxel in kras g12c mnsclc no responses in tumors w/ kras co-alterations signal of early progression in notch1m tumors that exhibited higher clinical benefit w/ docetaxel #lcsm #asco23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.